Anne-Marie Duliege,

Anne-Marie is currently Chief Medical Officer at Affymax, a California-based biopharmaceutical company focusing on peptide development. She has extensive experience in infectious diseases and immunology and has long been associated with many aspects of the fight against AIDS. She initially focused on understanding the transmission of HIV from mother to child and then participated in the testing of HIV drugs and potential vaccines, first at Genentech and, for the past twelve years, at Chiron. In these endeavors, she has collaborated with the National Institute of Health, the Army, several companies, and many medical centers in the U.S. and around the world. Dr. Duliege is also a Clinical Assistant Professor in the Department of Pediatrics Rheumatology at the Lucille Packard Children's Hospital at Stanford. Earlier on, Dr. Duliege was a Board member of S.O.S. Children Without Borders and was sent by several non-profit organizations on missions to practice medicine in African countries. Dr. Duliege has an MS in Epidemiology from Harvard School of Public Health, an MS in Biostatistics, a Doctorate in Medicine and a Board Certification in Pediatrics from Paris Hospitals.